US equities
|
MU
$983.23
▲+5.86%
META
$612.49
▼-1.24%
GOOGL
$324.89
▲+1.34%
NVDA
$215.38
▼-1.17%
MSFT
$531.01
▼-0.06%
TSLA
$404.22
▼-0.80%
SPCX
$145.23
▼-2.25%
SNDK
$1,404.77
▲+7.66%
MU
$983.23
▲+5.86%
META
$612.49
▼-1.24%
GOOGL
$324.89
▲+1.34%
NVDA
$215.38
▼-1.17%
MSFT
$531.01
▼-0.06%
TSLA
$404.22
▼-0.80%
SPCX
$145.23
▼-2.25%
SNDK
$1,404.77
▲+7.66%
FinancialContent
Sign in
Markets
Overview
News
World markets
Treasuries
Currencies
Commodities
Economy
Stocks
Overview
Most active
Gainers
Losers
Largest companies
52-week gainers
52-week losers
ETFs
Overview
Popular funds
Most active
Gainers
Losers
News
Research
Search
Sectors
Tools
My watchlist
My portfolio
Recent quotes
(OP:
GALDY
)
44.78
-0.10 (-0.22%)
Delayed Quote
Updated: 3:59 PM EDT, Oct 28, 2026
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about GALDY
The Aesthetics Giants Just Confirmed “Ozempic Face” Is Real — and a Newly Public Regenerative Player Wants to Compete for It
June 25, 2026
From
Biotech Insider
Via
GlobeNewswire
Walgreens Grows Specialty Pharmacy Network To Meet Rising Demand For Complex Therapies
↗
August 19, 2025
Walgreens boosts specialty drug network to 265 therapies, reinforcing its independent market position.
Via
Benzinga